– ISRAEL, Rehovot – AgPlenus Ltd., an innovative company designing novel and safe crop protection products, today announced the appointment of Dr. Adrian Percy (Ph.D.) to its Board of Directors, bringing a wealth of expertise and a deep commitment to advancing environmentally friendly agricultural technologies.
Dr. Percy has also been serving on the board of directors of Evogene Ltd. (TASE: EVGN | NASDAQ: EVGN) since March 2019, of whom AgPlenus is a subsidiary.
About Dr. Adrian Percy
With over 25 years of experience in the agricultural industry, Dr. Adrian Percy strongly advocates for environmentally friendly agricultural and food technologies to support global food supply and security. He has held senior management positions, including Head of Research & Development for Bayer’s Crop Science division, overseeing crop protection, seeds, traits, and regulatory affairs.
Dr. Percy’s academic background includes a bachelor’s degree in pharmacology from the University of Liverpool, a Master’s degree in Toxicology, and a doctorate in Biochemistry from the University of Birmingham. His expertise and passion make him a valuable addition to AgPlenus’ board of directors.
Dr. Adrian Percy said, “I am honored to join AgPlenus’ board of directors and contribute to developing sustainable crop protection solutions. AgPlenus’ commitment to leveraging computational biology and chemistry aligns with my vision for a more sustainable future in agriculture. I look forward to working closely with the board and management team to drive innovation and positively impact the industry.”
About AgPlenus Ltd.
AgPlenus is a platform company designing novel and safe crop protection products. At AgPlenus, we direct and accelerate the development of target-based novel crop protection products, utilizing a revolutionary tech engine based on AI combined with a deep understanding of biology and chemistry. By employing our target-based approach, we can minimize risks and enhance effectiveness, enabling us to fulfill our commitment to ensuring food security by overcoming global pesticide resistance. AgPlenus has ongoing collaborations with industry leaders such as Corteva. AgPlenus is a subsidiary of Evogene Ltd.
Source: www.agplenus.com
About Evogene Ltd.
Evogene is a computational biology company aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost. Evogene established three unique tech engines – MicroBoost AI, ChemPass AI, and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each tech engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene uses its tech engines to develop products through subsidiaries and strategic partnerships. Evogene’s subsidiaries currently utilize the tech engines to create human microbiome-based therapeutics by Biomica, ag-biologicals by Lavie Bio, ag-chemicals by AgPlenus, medical cannabis products by Canonic and castor varieties, for the biofuel and other industries, by Casterra.
For more information, www.evogene.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
